Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterogradedegeneration
I. Bechmann et al., Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterogradedegeneration, GLIA, 32(1), 2000, pp. 25-41
Tissue homeostasis is determined by a balance between proliferation and apo
ptosis. Various lesions in the brain are accompanied by proliferation and s
ubsequent death of glial cells, but the mechanisms that limit this expansio
n of glial populations remains unknown. One possible candidate is the death
ligand, FasL, and its receptor Fas, because the expression of both protein
s was reported on glial cells. To elucidate the expression and putative fun
ction of Fas and FasL on proliferative glial cells, we performed stereotact
ic lesion of the entorhinal cortex of adult rats. Such lesions induce proli
feration of astrocytes and microglial cells in the hippocampal fields of an
terograde degeneration. Subsequently, the total number of both cell types r
eturns to pre-lesion counts. We found that Fas and FasL is strongly upregul
ated on astrocytes in the zone of anterograde degeneration with a peak 5 da
ys postlesion (dpl) and a return to control levels at 10 dpl. However, evid
ence for astrocytic cell death was neither detected by TUNEL staining, immu
nocytochemistry for c-Jun, and apoptosis-specific protein (ASP), nor by sta
ining for morphologic hallmarks of apoptotic or necrotic cell death at the
light and electron microscopic level. Thus, increased expression of Fas and
FasL is not accompanied by cell death of reactive astrocytes during antero
grade degeneration. GLIA 32:25-41, 2000. (C) 2000 Wiley-Liss, Inc.